A major fire near Los Angeles. (Photo: Brian C. Weed, via Shutterstock)OPINION: Floods, mudslides, multi-year drought and massive, destructive wildland fires are only some of the extreme climate-related disasters California and its local communities face. If you live in California, the odds are that you are living in a danger zone.
The Lorry I. Lokey stem cell research building at Stanford University, a major facility of the California Institute for Regenerative Medicine. (Photo: CIRM)California’s $3 billion stem cell research program is looking for a new president to carry the state agency through what may be the last three years of its life. The search committee of the agency’s 29-member governing board meets July 17 to discuss the matter behind closed doors.
Former Assembloyman Roger Niello. (Photo: rogerniello.com)He was elected to his last term in the Assembly nearly a decade ago, but it’s hard to drive around Sacramento without seeing his name constantly. From Acura to Volvo, the Niello name can be found on license plate frames throughout the region.
A family pet receives care in a veterinary hospital. (Photo: Didesign021, via Shutterstock)A California statute governing blood-banking programs and transfusions for dogs has flown under the radar for the past 7 years, causing private veterinarians to break a law that they did not know existed. The issue would still be cloaked in obscurity had it not been for comments that emerged during a recent veterinary seminar at UC Davis.
A senior medical practitioner on the phone with hospital records. (Photo: sirtravelalot, via Shutterstock)OPINION: The California Assembly is currently considering a bill, Senate Bill 790, which would put in place severe restrictions around gifts or other financial benefits that pharmaceutical companies can give to medical professionals as part of marketing activities. Not only will the bill limit physician access to important information about new treatments, but it also insults the integrity of every physician practicing in California and is a threat to the patient-physician relationship.
U.S. Sen. Kamala Harris, D-California, questions a witness at a June 7 hearing of the Senate Intelligence Committee. (Photo: AP/Susan Walsh)Getting interrupted on two occasions during nationally televised Senate hearings has proved to be a political boon for Sen. Kamala Harris. California’s junior U.S. senator has drawn positive headlines and support on social media for what some perceive as sexist treatment by her Republican male colleagues. Media outlets across the country have identified Harris, a Democrat, as a possible presidential candidate in 2020, though she has said it is too early to think about that.
A photo illustration of human DNA. (Photo: Shutterstock)Plans to ask California voters in 2018 to approve a $5 billion bond issue to finance the California stem cell agency have been shelved, a director of the agency said Thursday. Jeff Sheehy, a San Francisco county supervisor, said that the key backer of the proposal had informed him that no bond measure would be offered to voters before 2020, presumably at the presidential general election.
Windmills generate electricity in Palm Springs. (Photo: Chris Rubino)OPINION: Clean energy is taking over the world, driven by a combination of climate change policies and market economics. California has paced America in seizing this opportunity, building a thriving green economy through smart policy. But the fate of California’s cap-and-trade program, a cornerstone of the state’s green growth strategy, depends on the state Legislature extending the program beyond 2020
Emergency workers at a Malibu auto accident on Pacific Coast Highway. (Photo: EGD, via Shutterstock)OPINION:Providers of emergency medical services across the state are opposing AB 263 authored by Assembly Member Freddie Rodriguez. Under the pretense of an “Emergency Worker Bill of Rights,” AB 263 is nothing short of a wolf in sheep’s clothing.
Human embryonic stem cells. (Photo: California Institute for Regenerative Medicine)California’s 12-year-old stem cell research effort is expected to give away tens of millions of dollars in public this week, but its most important matters — issues that deal with its survival and future — likely will be discussed behind closed doors at a meeting Thursday of its governing board. On the table is the leadership of the $3 billion organization, which is scheduled to run out of cash in just three years.